Does urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Sun Tae | - |
dc.contributor.author | Kim, Sang Woo | - |
dc.contributor.author | Kim, Jong Wook | - |
dc.contributor.author | Park, Hong Seok | - |
dc.contributor.author | Moon, Du Geon | - |
dc.contributor.author | Oh, Mi Mi | - |
dc.date.accessioned | 2021-09-01T12:29:24Z | - |
dc.date.available | 2021-09-01T12:29:24Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-07 | - |
dc.identifier.issn | 1341-321X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/64207 | - |
dc.description.abstract | This study was performed to evaluate what percentage of urinary tract infections (UTIs) caused by extended spectrum beta-lactamase (ESBL)-producing strains recurs with ESBL-producing strains during follow up and to assess the risk factors for recurrence with ESBL-producing Escherichia coli strains on subsequent first recurrence episode. We enrolled female patients with UTIs caused by ESBL-producing E. coli between May 2012 and December 2015, who were longitudinally followed up for at least 24 months. Among the 206 patients with ESBL positive UTI, 180 completed the study. 60 (60/180, 33.3%) of patient with first episode of UTI caused by ESBL-producing E. coli experienced recurrent UTIs during follow up. Of 60 patients, 43 (43/60, 71.7%) recurred with ESBL-producing E. coli on the first UTI recurrence episode. On multivariate analysis, the time to recurrence and history of cephalosporin usage in the last 6 months were identified as risk factors for recurrence with ESBL-producing E. coli per se (odds ratio [OR] = 0.9, 95% confidence interval [CI] 0.8-1.0, p = 0.030 and OR = 27.0, 95% CI 2.4-299.8, p = 0.007, respectively). These findings show that high proportion of patient with UTI caused by ESBL-producing E. coli recurs with ESBL-producing E. coli on subsequent recurrence episode. While result of antibiotic susceptibility cannot be identified on the visit day empirical treatment should be referred to the antecedent antibiotic resistance profile in patients whose previous UTIs were due to ESBL-producing strains. (c) 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.subject | ACUTE UNCOMPLICATED CYSTITIS | - |
dc.subject | ANTIMICROBIAL SUSCEPTIBILITY | - |
dc.subject | RISK-FACTORS | - |
dc.subject | ENTEROBACTERIACEAE | - |
dc.subject | GUIDELINES | - |
dc.subject | MANAGEMENT | - |
dc.subject | EMERGENCE | - |
dc.subject | STRAINS | - |
dc.subject | WOMEN | - |
dc.title | Does urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs? | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jong Wook | - |
dc.contributor.affiliatedAuthor | Park, Hong Seok | - |
dc.contributor.affiliatedAuthor | Moon, Du Geon | - |
dc.contributor.affiliatedAuthor | Oh, Mi Mi | - |
dc.identifier.doi | 10.1016/j.jiac.2019.02.006 | - |
dc.identifier.scopusid | 2-s2.0-85062333986 | - |
dc.identifier.wosid | 000469920600017 | - |
dc.identifier.bibliographicCitation | JOURNAL OF INFECTION AND CHEMOTHERAPY, v.25, no.7, pp.498 - 502 | - |
dc.relation.isPartOf | JOURNAL OF INFECTION AND CHEMOTHERAPY | - |
dc.citation.title | JOURNAL OF INFECTION AND CHEMOTHERAPY | - |
dc.citation.volume | 25 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 498 | - |
dc.citation.endPage | 502 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | ACUTE UNCOMPLICATED CYSTITIS | - |
dc.subject.keywordPlus | ANTIMICROBIAL SUSCEPTIBILITY | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | ENTEROBACTERIACEAE | - |
dc.subject.keywordPlus | GUIDELINES | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | EMERGENCE | - |
dc.subject.keywordPlus | STRAINS | - |
dc.subject.keywordPlus | WOMEN | - |
dc.subject.keywordAuthor | Urinary tract infection | - |
dc.subject.keywordAuthor | Extended-spectrum beta-lactamase | - |
dc.subject.keywordAuthor | Escherichia coli | - |
dc.subject.keywordAuthor | Longitudinal study | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.